Comparing rEBUS and transbronchial biopsy to subsequent surgical specimens revealed a 3% (n = 56) false negative rate among transbronchial biopsies for EGFR mutational analysis, a direct result of low tumor cell quantity in the associated specimens [64]. This evidence concerns the gene EGFR and neoplasm.